GlassScriptPhysician profile
Vincent E Paquette
NPI 1851385389
$3,457.12
in general payments reported to CMS, 2019-2025
21 companies · $936 in 2025
The $936 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.82 · 2020: $13.55 · 2021: $14.64 · 2022: $186 · 2023: $728 · 2024: $1,494 · 2025: $936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,158.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $967.38 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $468.59 | 2022-2025 | |
| Pfizer INC. | $468.15 | 2019-2025 | |
| Novo Nordisk INC | $322.76 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Corium, LLC | $284.19 | 2022-2025 | Azstarys |
| Glaxosmithkline, LLC. | $236.89 | 2020-2025 | Benlysta, Trelegy Ellipta, Arexvy |
| Sandoz INC. | $146.21 | 2023-2024 | Hyrimoz |
| Merck Sharp & Dohme LLC | $107.56 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Lilly USA, LLC | $91.19 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $82.62 | 2024-2025 | Cologuard Collection Kit |
| Janssen Biotech, INC. | $42.36 | 2024 | Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $29.60 | 2019 | |
| Inspire Medical Systems, INC. | $29.24 | 2025 | Inspire |
| Biohaven Pharmaceutical Holding Company LTD. | $27.95 | 2022 | |
| Novartis Pharmaceuticals Corporation | $26.58 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $21.85 | 2023 | Hadlima |
| Hologic Sales and Service, LLC | $21.54 | 2024 | Aptima, Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $21.30 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $20.82 | 2022 | |
| Sobi, INC | $20.33 | 2024 | |
| Stryker Corporation | $20.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Paquette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.